Abstract
Cancer is a lethal disease, and its therapy should be tailed to individual patients by functional imaging to optimize therapy strategies. Single-photon emission computed tomography (SPECT) is a quantitative functional imaging modality used by oncologists to monitor tumor response. SPECT can track therapy-induced biological and metabolic changes in tumors; such changes usually precede anatomical alterations. Assessment of treatment response using SPECT tracers may result in modifications in treatment planning and predicting the long-term outcome. These SPECT tracers can be classified into metabolism, cell surface receptor, intracellular receptor, microenvironment, and apoptosis tracers. The most widely used SPECT tracers include 201Tl-thallium chloride, 67Ga-gallium citrate, 123I/131I-sodium iodide, 99mmTc-MIBI, 99mTc-MDP, and 123I/131I –MIBG. Apoptosis tracers, which can directly monitor early tumor response in cancer patients and can predict the outcome, have attracted increasing attention in the field of oncology. Annexin V-based SPECT tracers, including 99mTc-BTAP-annexin V, 99mTc-HYNIC-annexin-V, 99mTc-EC-annexin-V, 99mTc-i-annexin V, and 123I-annexin V, have been evaluated in clinical trials. Novel SPECT tracers, such as radiolabeled small molecules, aptamers, peptides, and proteins, need to be explored in the future to further improve the outcome of cancer therapy. In this review, SPECT tracers used to predict and monitor cancer therapy in both preclinical and clinical settings are summarized. Some tracers may contribute to the improvement of cancer therapy management.
Keywords: Cancer therapy, Evaluation, Prediction, SPECT, Tracer.
Current Pharmaceutical Biotechnology
Title:Single-Photon Emission Computed Tomography Tracers for Predicting and Monitoring Cancer Therapy
Volume: 14 Issue: 7
Author(s): Jiong Cai and Fang Li
Affiliation:
Keywords: Cancer therapy, Evaluation, Prediction, SPECT, Tracer.
Abstract: Cancer is a lethal disease, and its therapy should be tailed to individual patients by functional imaging to optimize therapy strategies. Single-photon emission computed tomography (SPECT) is a quantitative functional imaging modality used by oncologists to monitor tumor response. SPECT can track therapy-induced biological and metabolic changes in tumors; such changes usually precede anatomical alterations. Assessment of treatment response using SPECT tracers may result in modifications in treatment planning and predicting the long-term outcome. These SPECT tracers can be classified into metabolism, cell surface receptor, intracellular receptor, microenvironment, and apoptosis tracers. The most widely used SPECT tracers include 201Tl-thallium chloride, 67Ga-gallium citrate, 123I/131I-sodium iodide, 99mmTc-MIBI, 99mTc-MDP, and 123I/131I –MIBG. Apoptosis tracers, which can directly monitor early tumor response in cancer patients and can predict the outcome, have attracted increasing attention in the field of oncology. Annexin V-based SPECT tracers, including 99mTc-BTAP-annexin V, 99mTc-HYNIC-annexin-V, 99mTc-EC-annexin-V, 99mTc-i-annexin V, and 123I-annexin V, have been evaluated in clinical trials. Novel SPECT tracers, such as radiolabeled small molecules, aptamers, peptides, and proteins, need to be explored in the future to further improve the outcome of cancer therapy. In this review, SPECT tracers used to predict and monitor cancer therapy in both preclinical and clinical settings are summarized. Some tracers may contribute to the improvement of cancer therapy management.
Export Options
About this article
Cite this article as:
Cai Jiong and Li Fang, Single-Photon Emission Computed Tomography Tracers for Predicting and Monitoring Cancer Therapy, Current Pharmaceutical Biotechnology 2013; 14 (7) . https://dx.doi.org/10.2174/1389201014666131226105651
DOI https://dx.doi.org/10.2174/1389201014666131226105651 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Radiolabeled Glucose Derivatives for Tumor Imaging Using SPECT and PET
Current Medicinal Chemistry Postoperative Radiotherapy After Radical Prostatectomy: Adjuvant or Salvage?
Current Cancer Therapy Reviews Mesenchymal Stem Cells for Treatment of CNS Injury
Current Neuropharmacology Medication-Induced Acute Abdominal Pain: Evaluation with CT Imaging
Current Medical Imaging Anticancer Advances of Matrine and Its Derivatives
Current Pharmaceutical Design Antibody Targeting of TGF-β in Cancer Patients
Current Pharmaceutical Biotechnology Phenolics and Terpenoids; the Promising New Search for Anthelmintics: A Critical Review
Mini-Reviews in Medicinal Chemistry E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets
Current Cancer Drug Targets Graphene Oxide: A Carrier for Pharmaceuticals and a Scaffold for Cell Interactions
Current Topics in Medicinal Chemistry The Chemistry and Bio-Medicinal Significance of Pyrimidines & Condensed Pyrimidines
Current Topics in Medicinal Chemistry Studies on Anticancer Activities of Lactoferrin and Lactoferricin
Current Protein & Peptide Science In Situ Gene Therapy for Prostate Cancer
Current Gene Therapy Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine
Anti-Cancer Agents in Medicinal Chemistry Chromatin Remodeling Agents for Cancer Therapy
Reviews on Recent Clinical Trials Oxidative stress in carcinogenesis: new synthetic compounds with dual effects upon free radicals and cancer.
Current Medicinal Chemistry Urinary Tract Tumors, Biology and Risk for Artificial Sweeteners Use with Particular Emphasis on some South American Countries
Current Nutrition & Food Science Hypoxia: Targeting the Tumour
Anti-Cancer Agents in Medicinal Chemistry Alkaloids as Important Scaffolds in Therapeutic Drugs for the Treatments of Cancer, Tuberculosis, and Smoking Cessation
Current Topics in Medicinal Chemistry Human Amniotic Fluid Stem Cells as an Attractive Tool for Clinical Applications
Current Stem Cell Research & Therapy Pleiotropic Effects of Cathepsin D
Endocrine, Metabolic & Immune Disorders - Drug Targets